Splash Beverage Group (NYSE American: SBEV) Reports Third Quarter 2023 Financial Results, Quarterly Revenues Rise 5%, Nine Month Revenues Rise 22%

FORT LAUDERDALE, FL, Nov. 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today reported financial results for the third quarter period ended September 30, 2023. Investors are encouraged to read the Company’s quarterly report on Form 10-Q which was filed with […]

NanoViricides (NYSE American: NNVC) Has Filed its Quarterly Report – NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications

SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2023 with the Securities and Exchange Commission (SEC) on Tuesday, November 14, 2023. The report can be accessed at the SEC website […]

SciSparc (NASDAQ: SPRC) Celebrates Major Breakthrough: Positive Results Show its Treatment has a Remarkable Impact on Alzheimer’s Agitation

Phase IIa trial outcome indicates the potential for a new way to help Alzheimer’s patients’ agitation Tel-Aviv, Nov. 15, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), unveiled positive topline results from […]

American Rebel (NASDAQ: AREB) Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2023

Nashville, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer, announced its financial results for the three- and nine-month periods ended September 30, 2023. Investors are encouraged […]

Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development

SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the “Company”), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reports that its broad-spectrum antiviral drug candidate, NV-387 was highly effective in an animal model that is used in drug development for MPox and Smallpox virus infections in […]

DSS Inc. (NYSE American: DSS) Wins Patent Dispute with Nichia Corporation

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS) announced today that, in a unan​i​mous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.’s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges […]

Sadot Group Inc. (Nasdaq:SDOT) Announces Third Quarter 2023 Conference Call

FORT WORTH, TX / ACCESSWIRE / November 10, 2023 / Sadot Group Inc. (Nasdaq:SDOT) (the “Sadot Group” or the “Company”), an emerging player in the global food supply chain sector, today announced that the Company plans to file their results for the quarter ending September 30, 2023, on Tuesday November 14th, 2023. Sadot Group Inc. will then […]

Long-term Survival Data from Longeveron’s (NASDAQ: LGVN) ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association

Extended Follow Up Data Show Continued, Transplant Free Survival of All Patients Results Support Continued Investigation of Lomecel-BTM As Adjunct to Stage II Surgery in HLHS – Enrollment ongoing in Phase 2 ELPIS II trial – MIAMI, Nov. 11, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical-stage biotechnology company […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.